Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
23.11
-0.31 (-1.32%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.67 billion as of July 24, 2026. Its market cap has increased by 74.48% in one year.
Market Cap
3.67B
Enterprise Value
2.66B
1-Year Change
74.48%
Ranking
Category
Stock Price
$23.11
ChartMarket Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.67B, an increase of 94.35%. That is a compound annual growth rate of 8.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.67B | 51.47% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Parabilis Medicines | 4.04B |
| Tango Therapeutics | 3.96B |
| Dyne Therapeutics | 3.92B |
| Arcus Biosciences | 3.79B |
| Enliven Therapeutics | 3.68B |
| Structure Therapeutics | 3.64B |
| NewAmsterdam Pharma Company | 3.63B |
| Telix Pharmaceuticals | 3.59B |